Although it is not yet known how long the vaccine against the last, it is thought likely to be required each year, as the flu jab, because a slightly different version of the virus may come out of the season.
Last month, Alok Sharma, the business Secretary, said Britain would be the first country in the world to get a vaccine should trials of success, and has announced an extra £84 million in funding to accelerate research.
The Oxford vaccine is currently the most advanced in human trials of all vaccines in development, and Professor Sara Gilbert, leader of the research, has predicted he could be ready for the beginning of the fall.
Speaking earlier this month, Professor Gilbert said that the trial may need to move to other countries because the infection rates were now so low in Britain that it was difficult to know whether the vaccine was working.
“We had hoped to have enough people vaccinated before the epidemic reached a peak, but the virus spread quickly, triggering a lockdown, and infection rates are now falling,” she said of the United Nations to the ambassadors. “At least some of the trial participants become infected, we may not know that the vaccine is effective.
“We are therefore focusing on the vaccination of health care workers, because they have the highest rate of infections by the virus. In addition, as measures to facilitate the locking are introduced, the transmission can rise again.
“We need to manufacture more of the vaccine for testing, and the plan to begin testing in more than one country to give us the best chance to determine the effectiveness of the vaccine. “
The united KINGDOM of the first Vaccine plant Innovation Centre in Harwell, Oxfordshire, will be operational by next summer, and able to produce enough vaccine for the entire population within a period of six months.